HK Stock MarketDetailed Quotes

03347 TIGERMED

Watchlist
  • 29.450
  • -0.350-1.17%
Not Open Aug 30 16:08 CST
25.47BMarket Cap20.55P/E (TTM)

About TIGERMED Company

The company is an industry-leading integrated biomedical R&D service platform, providing innovative R&D solutions spanning the full cycle for the global pharmaceutical and medical device industry. Through a comprehensive service system and top quality standards, we help the biomedical industry improve R&D efficiency, reduce R&D risks, ensure high-quality delivery of research projects, accelerate the marketization process of pharmaceutical products, and fulfill our promises to the industry and patients. The company is a contract research organization (CRO) focusing on providing professional services throughout the clinical trial process for new drug research and development. It provides comprehensive and comprehensive clinical research solutions for global pharmaceutical and medical device innovators, ensures research quality, reduces R&D risks, shortens R&D cycles, saves R&D expenses, and promotes the product marketization process, so that patients can use newer and better pharmaceuticals and medical products as soon as possible. The services provided by the company mainly include clinical trial technical services and clinical trial-related services and laboratory services. Corporate honors: Eli Lilly Global Supplier Award, MSD Supplier Outstanding Service Award, Top 10 Listed Chinese Pharmaceutical Companies with the Most Investment Value, etc.

Company Profile

Symbol03347
Company NameTIGERMED
ISINCNE1000040M1
Listing DateAug 7, 2020
Issue Price100.00
Shares Offered107.07M share(s)
FoundedDec 15, 2004
Registered AddressChina
Chairmanxiaoping ye
Secretarymeiyi weng
Audit InstitutionHong Kong Lixin Dehao Certified Public Accountants Limited, Lixin Certified Public Accountants (Special General Partnership)
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeRoom 2001-2010, 20th Floor, Building 8, No. 19, Jugong Road, Xixing Street, Binjiang District, Hangzhou, Zhejiang
Head Office and Principal Place of Business40th Floor, Dah Sing Financial Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees9348
MarketHong Kong motherboard
Phone0571-28887227
Fax0571-88211196
Emailir@tigermedgrp.com
BusinessServices: Technology development, technical consulting, transfer of results for pharmaceutical-related industrial products and health-related industry products, management and statistical analysis of clinical trial data, translation, information technology and business process outsourcing services such as data processing by means of outsourced services, uncertified labor vocational skills training for adults, non-cultural education and training for adults, collection, collation, storage and publication of information on talent supply and demand, conduct job placement, and conduct personnel information consulting. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • xiaoping ye
  • Chairman, Executive Director, Chairman of the Strategic Development Committee, Authorized Representative
  • 2.92M
  • xiaochun cao
  • Executive Director, General Manager, Remuneration Committee Members
  • 1.16M
  • hao wu
  • Co-President, Executive Director, Member of the Strategic Development Committee
  • 2.61M
  • zengyu wen
  • Executive Vice President, Executive Director, Deputy General Manager, Chief Operating Officer, Nomination Committee Members
  • 1.20M
  • qiyu liao
  • Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
  • 220.00K
  • huagang yuan
  • Independent Non-Executive Director, Remuneration Committee Chairman, Member of the Strategic Development Committee, Audit Committee Members
  • 122.00K
  • yuwen liu
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Member of the Strategic Development Committee, Audit Committee Members
  • --
  • binghui zhang
  • Chairman of the Supervisory Board, Non-employee Representative Supervisors
  • 80.00K
  • zhimin chen
  • Shareholder Supervisors
  • 80.00K
  • wenqing lou
  • Employee Representative Supervisor
  • 140.00K
  • chengcheng yang
  • Head of Finance, Responsible Accounting Officer
  • --
  • xiaori li
  • Board Secretary
  • --
  • meiyi weng
  • Authorized Representative, Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg